Skip to main content
BLFS
NASDAQ Industrial Applications And Services

BioLife Solutions Reports Strong Q4 & FY25 Results, Guides for 2026 GAAP Profitability

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$23.08
Mkt Cap
$1.082B
52W Low
$19.1
52W High
$29.62
52W Position info
21% above low
Off High info
22% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

BLFS sits 21% above its 52-week low of $19.1 on elevated volume (2.1× avg).

Summary

BioLife Solutions announced robust fourth quarter and full year 2025 financial results, exceeding revenue expectations and projecting a return to full-year GAAP profitability in 2026.


Key Events · Earnings and Guidance · BLFS

  • Strong Q4 & FY25 Revenue Growth

    Reported Q4 2025 revenue of $24.8 million, an increase of 20% year-over-year, and full year 2025 revenue of $96.2 million, up 29% year-over-year.

  • Return to Q4 GAAP Profitability

    Achieved GAAP net income of $2.1 million, or $0.04 per share, for Q4 2025, reversing a net loss of $1.2 million in Q4 2024.

  • Positive 2026 Financial Guidance

    Introduced 2026 revenue guidance of $112.5 million to $115.0 million, representing 17% to 20% growth, and expects full-year GAAP profitability.

  • Adjusted EBITDA Expansion

    Reported Q4 2025 Adjusted EBITDA of $6.9 million (28% of revenue) and FY 2025 Adjusted EBITDA of $25.0 million (26% of revenue), with continued expansion expected in 2026.


Analysis · BLFS · Industrial Applications And Services

This filing provides the full financial results for Q4 and full year 2025, building on the preliminary revenue announced in January. The company reported significant revenue growth and a positive shift to GAAP net income in Q4 2025. Most notably, BioLife Solutions introduced 2026 guidance that includes an expectation of full-year GAAP profitability, a key milestone following its strategic divestitures to become a focused cell processing company. This outlook, coupled with strong adjusted EBITDA expansion, signals improved operational efficiency and a positive trajectory for the company's financial health.

At the time of this filing, BLFS was trading at $23.08 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $19.10 to $29.62. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BLFS - Latest Insights

BLFS
Jul 23, 2026, 6:21 PM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $31.02
Real-time Price: $31.86 info
Change: +$0.835 (+3%) info
Market Cap: $1.558B info
BLFS
Jul 22, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $31.00
Real-time Price: $31.86 info
Change: +$0.855 (+3%) info
Market Cap: $1.558B info
BLFS
Jul 22, 2026, 6:57 AM EDT
Source: Reuters
Importance Score:
10
Price at Filing: $29.19
Real-time Price: $31.86 info
Change: +$2.66 (+9%) info
Market Cap: $1.558B info
BLFS
Jun 26, 2026, 6:25 PM EDT
Source: Binance News
Importance Score:
9
Price at Filing: $30.55
Real-time Price: $31.86 info
Change: +$1.30 (+4%) info
Market Cap: $1.558B info
BLFS
Jun 03, 2026, 8:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $27.49
Real-time Price: $31.86 info
Change: +$4.37 (+16%) info
Market Cap: $1.558B info